Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation

Annals of Hematology

Volumn 91, Issue 12, 2012, Pages 1959-1968

  Edwards, Christine Priscilla ^a   Shehata, Nadine ^a,b   Faughnan, Marie E ^a,b,c,d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anticoagulant; Anticoagulation; Arteriovenous malformation; Hereditary hemorrhagic telangiectasia; Telangiectasia

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANEMIA; ANTICOAGULATION; ARTICLE; BLEEDING DISORDER; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEATH; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH SURVEY; HEMATOTHORAX; HOSPITAL ADMISSION; HUMAN; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; RETROSPECTIVE STUDY; TONGUE DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTERIOVENOUS MALFORMATIONS; DRUG MONITORING; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALS, UNIVERSITY; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; ONTARIO; PLATELET AGGREGATION INHIBITORS; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TERTIARY CARE CENTERS; THROMBOEMBOLISM;

EID: 84871008266     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1553-8     Document Type: Article

References (28)

1. Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333(14):918-924
2. Shovlin CL, Sulaiman NL, Govani FS, Jackson JE, Begbie ME (2007) Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism. Thromb Haemost 98(5):1031-1039. doi:07111031[pii]
3. Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245(1):31-39
4. Lesca G, Olivieri C, Burnichon N, Pagella F, Carette MF, Gilbert-Dussardier B, Goizet C, Roume J, Rabilloud M, Saurin JC, Cottin V, Honnorat J, Coulet F, Giraud S, Calender A, Danesino C, Buscarini E, Plauchu H (2007) Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med 9(1):14-22
5. Letteboer TG, Mager HJ, Snijder RJ, Lindhout D, Ploos van Amstel HK, Zanen P, Westermann KJ (2008) Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia. Am J Med Genet A 146A(21):2733-2739. doi:10.1002/ajmg.a.32243
6. Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ (2006) Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 43(4):371-377. doi:10.1136/jmg.2005. 035451
7. Sabba C, Pasculli G, Lenato GM, Suppressa P, Lastella P,Memeo M, Dicuonzo F, Guant G (2007) Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5(6):1149-1157. doi:10.1111/j.1538-7836.2007.02531.x
8. van Gent MW, Post MC, Luermans JG, Snijder RJ, Westermann CJ, Plokker HW, Overtoom TT, Mager JJ (2008) Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study. Eur Respir J. doi:10.1183/09031936.00049008
9. Westermann CJ, Rosina AF, De Vries V, de Coteau PA (2003) The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A 116A(4):324-328. doi:10.1002/ajmg.a.10002
10. Plauchu H, de Chadarevian JP, Bideau A, Robert JM (1989) Agerelated clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32 (3):291-297. doi:10.1002/ajmg.1320320302
11. Porteous ME, Burn J, Proctor SJ (1992) Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 29(8):527-530
12. Assar OS, Friedman CM, White RI Jr (1991) The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 101(9):977-980
13. Haitjema T, BalderW, Disch FJ,Westermann CJ (1996) Epistaxis in hereditary haemorrhagic telangiectasia. Rhinology 34(3):176-178
14. Pasculli G, Resta F, Guastamacchia E, Di Gennaro L, Suppressa P, Sabba C (2004) Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler- Weber disease. Qual Life Res 13(10):1715-1723
15. Geisthoff UW, Heckmann K, D'Amelio R, Grunewald S,Knobber D, Falkai P, Konig J (2007) Health-related quality of life in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 136 (5):726-733. doi:10.1016/j. otohns.2006.12.019, discussion 734-725
16. Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, Fayad PB, Awad IA, White RI Jr (1998) MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 19(3):477-484
17. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW (1995) Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 99(5):519-524
18. Maher CO, Piepgras DG, Brown RD Jr, Friedman JA, Pollock BE (2001) Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 32(4):877-882
19. Ni Bhuachalla CF, O'Connor TM, Murphy M, Colwell N, Brady A (2010) Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008. Respir Med 104 (8):1218-1224. doi:10.1016/j.rmed.2010. 03.003
20. Haitjema TJ, Overtoom TT, Westermann CJ, Lammers JW (1995) Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. Thorax 50(7):719-723
21. Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF (2004) Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 169(9):994-1000. doi:10.1164/rccm. 200310-1441OC
22. Kjeldsen AD, Kjeldsen J (2000) Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 95(2):415-418. doi:10.1111/j.1572-0241.2000. 01792.x
23. Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, Gedge F, Tang W, Coon H, Mao R (2006) Genotype- phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A 140(5):463-470. doi:10.1002/ajmg.a.31101
24. Sturm W, Gaenzer H, Heininger-Rothbucher D, Neumayr G, Kirchmair R, Patsch J, Weiss G (2003) Unsuspected mesenteric vein thrombosis in a patient with a hereditary bleeding disorder. Blood Coagul Fibrinolysis 14:599-600
25. Goodenberger D, Chakinala M, Picus D (2009) Management of venous thromboembolism in hereditary hemorrhagic telangiectasia. Hematol Meet Rep 3(4):11
26. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91 (1):66-67. doi:10.1002/(SICI)1096-8628(20000306)91:1<66:: AID-AJMG12>3.0.CO;2-P
27. Gallitelli M, Pasculli G, Fiore T, Carella A, Sabba C (2006) Emergencies in hereditary haemorrhagic telangiectasia. QJM: Int J Med 99(1):15-22. doi:10.1093/qjmed/hci148
28. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH (1996) The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 124 (11):970-979